Multiple binding modes of ibuprofen in human serum albumin identified by absolute binding free energy calculations
暂无分享,去创建一个
David L Mobley | Bruno Rizzuti | D. Mobley | R. Guzzi | B. Rizzuti | Stefania Evoli | Rita Guzzi | Stefania Evoli
[1] R. Dror,et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field , 2010, Proteins.
[2] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[3] Thomas Simonson,et al. An Overview of Electrostatic Free Energy Computations for Solutions and Proteins. , 2014, Journal of chemical theory and computation.
[4] B. Rizzuti,et al. Stability of trans-resveratrol associated with transport proteins. , 2014, Journal of agricultural and food chemistry.
[5] J. Seibold,et al. Pharmacokinetics and Bioinversion of Ibuprofen Enantiomers in Humans , 1994, Pharmaceutical Research.
[6] Peter M. Kasson,et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..
[7] T. Imai,et al. Study of interaction of carprofen and its enantiomers with human serum albumin--II. Stereoselective site-to-site displacement of carprofen by ibuprofen. , 1993, Biochemical pharmacology.
[8] Charles L. Brooks,et al. Free energy screening of small ligands binding to an artificial protein cavity , 2000 .
[9] Emil Alexov,et al. Protonation and pK changes in protein–ligand binding , 2013, Quarterly Reviews of Biophysics.
[10] R. Guzzi,et al. Fatty acid binding into the highest affinity site of human serum albumin observed in molecular dynamics simulation. , 2015, Archives of biochemistry and biophysics.
[11] T. R. C. Guizado,et al. Analysis of the structure and dynamics of human serum albumin , 2014, Journal of Molecular Modeling.
[12] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[13] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[14] Christopher I. Bayly,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation , 2002, J. Comput. Chem..
[15] David L. Mobley,et al. Guidelines for the analysis of free energy calculations , 2015, Journal of Computer-Aided Molecular Design.
[16] Dragana Mutavdžić Pavlović,et al. Determination of p K a values of active pharmaceutical ingredients , 2007 .
[17] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[18] O. Dangles,et al. Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. , 2005, Biochimica et biophysica acta.
[19] M. Rosales-Hernández,et al. Exploration of human serum albumin binding sites by docking and molecular dynamics flexible ligand-protein interactions. , 2010, Biopolymers.
[20] Stefan Boresch,et al. Absolute Binding Free Energies: A Quantitative Approach for Their Calculation , 2003 .
[21] Jennifer L. Knight,et al. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. , 2015, Journal of the American Chemical Society.
[22] G. Sudlow,et al. The characterization of two specific drug binding sites on human serum albumin. , 1975, Molecular pharmacology.
[23] S. Curry,et al. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. , 2000, Journal of molecular biology.
[24] K. Dill,et al. Blind prediction of charged ligand binding affinities in a model binding site. , 2013, Journal of molecular biology.
[25] David L Mobley,et al. The Confine-and-Release Method: Obtaining Correct Binding Free Energies in the Presence of Protein Conformational Change. , 2007, Journal of chemical theory and computation.
[26] R. Zwanzig. High‐Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases , 1954 .
[27] J. Simon,et al. Interaction of ochratoxin A with human serum albumin. Binding sites localized by competitive interactions with the native protein and its recombinant fragments. , 2002, Chemico-biological interactions.
[28] P. Deuflhard,et al. Robust Perron cluster analysis in conformation dynamics , 2005 .
[29] V. Trezza,et al. Human serum albumin: from bench to bedside. , 2012, Molecular aspects of medicine.
[30] P. Kollman,et al. Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.
[31] David L Mobley,et al. Alchemical free energy methods for drug discovery: progress and challenges. , 2011, Current opinion in structural biology.
[32] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[33] Michael R. Shirts,et al. Statistically optimal analysis of samples from multiple equilibrium states. , 2008, The Journal of chemical physics.
[34] J. Estelrich,et al. Binding of non-steroidal anti-inflammatory drugs to human serum albumin , 1990 .
[35] C. Riley,et al. The Effect of Octanoic Acid on the Binding of the Enantiomers of Ibuprofen and Naproxen to Human Serum Albumin: A Chromatographic Implication , 2004, Pharmaceutical Research.
[36] K. Dill,et al. On the use of orientational restraints and symmetry corrections in alchemical free energy calculations. , 2006, The Journal of chemical physics.
[37] T. Amisaki,et al. Identification of high affinity fatty acid binding sites on human serum albumin by MM-PBSA method. , 2008, Biophysical journal.
[38] C. Riley,et al. A quantitative circular dichroic investigation of the binding of the enantiomers of ibuprofen and naproxen to human serum albumin. , 1997, Journal of pharmaceutical and biomedical analysis.
[39] D. Mobley,et al. Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration. , 2013, Journal of medicinal chemistry.
[40] Y. Tsuda,et al. Stereoselectivity and enantiomer-enantiomer interactions in the binding of ibuprofen to human serum albumin. , 1997, Chirality.
[41] Dragana Mutavdžić Pavlović,et al. Determination of pKa values of active pharmaceutical ingredients , 2007 .
[42] P. Ascenzi,et al. Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. A spectroscopic study. , 2001, European journal of biochemistry.
[43] P. Ascenzi,et al. Ibuprofen binding to secondary sites allosterically modulates the spectroscopic and catalytic properties of human serum heme–albumin , 2011, The FEBS journal.
[44] S. Curry,et al. Structural basis of the drug-binding specificity of human serum albumin. , 2005, Journal of molecular biology.
[45] P. Brick,et al. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites , 1998, Nature Structural Biology.
[46] David L Mobley,et al. Calculating the binding free energies of charged species based on explicit-solvent simulations employing lattice-sum methods: an accurate correction scheme for electrostatic finite-size effects. , 2013, The Journal of chemical physics.
[47] Berk Hess,et al. P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation. , 2008, Journal of chemical theory and computation.
[48] Chris Oostenbrink,et al. Net charge changes in the calculation of relative ligand-binding free energies via classical atomistic molecular dynamics simulation , 2013, J. Comput. Chem..
[49] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..
[50] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[51] Christophe Chipot,et al. Standard binding free energies from computer simulations: What is the best strategy? , 2013, Journal of chemical theory and computation.
[52] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[53] Emilio Gallicchio,et al. Advances in all atom sampling methods for modeling protein-ligand binding affinities. , 2011, Current opinion in structural biology.
[54] Julien Michel,et al. Current and emerging opportunities for molecular simulations in structure-based drug design , 2014, Physical chemistry chemical physics : PCCP.
[55] G. Elta,et al. Stereoselective, competitive, and nonlinear plasma protein binding of ibuprofen enantiomers as determinedin vivo in healthy subjects , 1993, Journal of Pharmacokinetics and Biopharmaceutics.
[56] K. Szlachta,et al. Crystal structure of equine serum albumin in complex with cetirizine reveals a novel drug binding site. , 2016, Molecular immunology.
[57] David L Mobley,et al. Perspective: Alchemical free energy calculations for drug discovery. , 2012, The Journal of chemical physics.
[58] Enzo Terreno,et al. The extraordinary ligand binding properties of human serum albumin , 2005, IUBMB life.
[59] J. Rose,et al. Structural studies of several clinically important oncology drugs in complex with human serum albumin. , 2013, Biochimica et biophysica acta.
[60] M. Otagiri,et al. Species Differences of Serum Albumins: I. Drug Binding Sites , 1997, Pharmaceutical Research.
[61] M. J. Crooks,et al. Binding of nonsteroidal anti-inflammatory agents to proteins--I. Ibuprofen-serum albumin interaction. , 1979, Biochemical pharmacology.
[62] Thomas Fox,et al. Accuracy Assessment and Automation of Free Energy Calculations for Drug Design , 2014, J. Chem. Inf. Model..
[63] D. S. Hage,et al. Characterization of the protein binding of chiral drugs by high-performance affinity chromatography. Interactions of R- and S-ibuprofen with human serum albumin. , 1995, Journal of chromatography. A.